K M Bond1, W Brinjikji2, M H Murad3, D F Kallmes4, H J Cloft4, G Lanzino5. 1. From the Mayo Medical School (K.M.B.). 2. Department of Radiology (W.B., D.F.K., H.J.C.) brinjikji.waleed@mayo.edu. 3. Center for Science of Healthcare Delivery (M.H.M.). 4. Department of Radiology (W.B., D.F.K., H.J.C.). 5. Department of Neurologic Surgery (G.L.), Mayo Clinic, Rochester, Minnesota.
Abstract
BACKGROUND AND PURPOSE: Endovascular treatment of intracranial aneurysms is associated with the risk of thromboembolic ischemic complications. Many of these events are asymptomatic and identified only on diffusion-weighted imaging. We performed a systematic review and meta-analysis to study the incidence of DWI positive for thromboembolic events following endovascular treatment of intracranial aneurysms. MATERIALS AND METHODS: A comprehensive literature search identified studies published between 2000 and April 2016 that reported postprocedural DWI findings in patients undergoing endovascular treatment of intracranial aneurysms. The primary outcome was the incidence of DWI positive for thromboembolic events. We examined outcomes by treatment type, sex, and aneurysm characteristics. Meta-analyses were performed by using a random-effects model. RESULTS: Twenty-two studies with 2148 patients and 2268 aneurysms were included. The overall incidence of DWI positive for thromboembolic events following endovascular treatment was 49% (95% CI, 42%-56%). Treatment with flow diversion trended toward a higher rate of DWI positive for lesions than coiling alone (67%; 95% CI, 46%-85%; versus 45%; 95% CI, 33%-56%; P = .07). There was no difference between patients treated with coiling alone and those treated with balloon-assisted (44%; 95% CI, 29%-60%; P = .99) or stent-assisted (43%; 95% CI, 24%-63%; P = .89) coiling. Sex, aneurysm rupture status, location, and size were not associated with the rate of DWI positive for lesions. CONCLUSIONS: One in 2 patients may have infarcts on DWI following endovascular treatment of intracranial aneurysms. There is a trend toward a higher incidence of DWI-positive lesions following treatment with flow diversion compared with coiling. Patient demographics and aneurysm characteristics were not associated with DWI-positive thromboembolic events.
BACKGROUND AND PURPOSE: Endovascular treatment of intracranial aneurysms is associated with the risk of thromboembolic ischemic complications. Many of these events are asymptomatic and identified only on diffusion-weighted imaging. We performed a systematic review and meta-analysis to study the incidence of DWI positive for thromboembolic events following endovascular treatment of intracranial aneurysms. MATERIALS AND METHODS: A comprehensive literature search identified studies published between 2000 and April 2016 that reported postprocedural DWI findings in patients undergoing endovascular treatment of intracranial aneurysms. The primary outcome was the incidence of DWI positive for thromboembolic events. We examined outcomes by treatment type, sex, and aneurysm characteristics. Meta-analyses were performed by using a random-effects model. RESULTS: Twenty-two studies with 2148 patients and 2268 aneurysms were included. The overall incidence of DWI positive for thromboembolic events following endovascular treatment was 49% (95% CI, 42%-56%). Treatment with flow diversion trended toward a higher rate of DWI positive for lesions than coiling alone (67%; 95% CI, 46%-85%; versus 45%; 95% CI, 33%-56%; P = .07). There was no difference between patients treated with coiling alone and those treated with balloon-assisted (44%; 95% CI, 29%-60%; P = .99) or stent-assisted (43%; 95% CI, 24%-63%; P = .89) coiling. Sex, aneurysm rupture status, location, and size were not associated with the rate of DWI positive for lesions. CONCLUSIONS: One in 2 patients may have infarcts on DWI following endovascular treatment of intracranial aneurysms. There is a trend toward a higher incidence of DWI-positive lesions following treatment with flow diversion compared with coiling. Patient demographics and aneurysm characteristics were not associated with DWI-positive thromboembolic events.
Authors: Colin P Derdeyn; DeWitte T Cross; Christopher J Moran; George W Brown; Thomas K Pilgram; Michael N Diringer; Robert L Grubb; Keith M Rich; Michael R Chicoine; Ralph G Dacey Journal: J Neurosurg Date: 2002-05 Impact factor: 5.115
Authors: Sarah E Vermeer; Niels D Prins; Tom den Heijer; Albert Hofman; Peter J Koudstaal; Monique M B Breteler Journal: N Engl J Med Date: 2003-03-27 Impact factor: 91.245
Authors: Tamer Altay; Hee I Kang; Henry H Woo; Thomas J Masaryk; Peter A Rasmussen; David J Fiorella; Shaye I Moskowitz Journal: J Neurointerv Surg Date: 2011-01-08 Impact factor: 5.836
Authors: Lee A Tan; Kiffon M Keigher; Stephan A Munich; Roham Moftakhar; Demetrius K Lopes Journal: J Neurointerv Surg Date: 2014-02-19 Impact factor: 5.836
Authors: M L Hahnemann; A Ringelstein; I E Sandalcioglu; S Goericke; C Moenninghoff; I Wanke; M Forsting; U Sure; M Schlamann Journal: J Neurointerv Surg Date: 2013-08-08 Impact factor: 5.836
Authors: Seyed Mohammad Seyedsaadat; Leonardo Rangel Castilla; Giuseppe Lanzino; Harry J Cloft; Daniel J Blezek; Amy Theiler; Ramanathan Kadirvel; Waleed Brinjikji; David F Kallmes Journal: Neuroradiol J Date: 2019-04-03
Authors: D H Yoo; Y D Cho; H S Lee; S H Kim; D Jang; S H Lee; W-S Cho; H-S Kang; J E Kim; M H Han Journal: AJNR Am J Neuroradiol Date: 2020-04 Impact factor: 3.825
Authors: Sang Hyuk Lee; Seung Hwan Kim; Ji Hwan Jang; Young Zoon Kim; Kyu Hong Kim; Taek Min Nam Journal: J Cerebrovasc Endovasc Neurosurg Date: 2022-09-06
Authors: Axel Rosengart; Malie K Collins; Philipp Hendrix; Ryley Uber; Melissa Sartori; Abhi Jain; Jennifer Mao; Oded Goren; Clemens M Schirmer; Christoph J Griessenauer Journal: Interv Neuroradiol Date: 2021-02-04 Impact factor: 1.764
Authors: Damian Kocur; Piotr Paździora; Nikodem Przybyłko; Wojciech Kukier; Jan Baron; Adam Rudnik Journal: Wideochir Inne Tech Maloinwazyjne Date: 2019-10-17 Impact factor: 1.195
Authors: Marta Aguilar Perez; Victoria Hellstern; Carmen Serna Candel; Christina Wendl; Hansjörg Bäzner; Oliver Gansladt; Hans Henkes Journal: Stroke Vasc Neurol Date: 2020-09-12